The Ovary Doesn’t Retire After Menopause

TL;DR

Before you orderOffer from Amazon

Get workout gear delivered free with Prime

• Fast, free delivery on millions of items
• Prime Video, Amazon Music and more included
• Member-only deals all year

Start your free Prime trial →Free trial for eligible customers · Cancel anytime

As an affiliate, we earn on qualifying purchases.Hide

A study published Oct. 14 in Aging Cell found that ovaries from 28 postmenopausal women continued to show age-related molecular and tissue changes. Researchers also identified patterns associated with ovarian cancer, but the study does not show that the changes cause cancer or establish whether they are harmful or beneficial.

A study of 28 postmenopausal ovaries found that the organs continue to change with age, showing differences in proteins linked to inflammation, immune activity and tissue remodeling. Published Oct. 14 in Aging Cell, the research by scientists at Northwestern University and the Buck Institute for Research on Aging also identified molecular patterns associated with ovarian cancer, but does not establish that the changes cause cancer or harm women.

The researchers analyzed ovarian tissue from women ages 50 to 75, using proteomic methods and mass spectrometry to examine 5,812 groups of proteins. The study focused on a relatively narrow postmenopausal age range, allowing the team to look for differences that develop after reproductive function has ended rather than comparing ovaries across a person’s whole lifespan. The authors said human ovarian tissue is difficult to obtain, making the 28 samples a valuable, but limited, collection.

In younger postmenopausal ovaries, the team found more proteins involved in maintaining cells and tissue structure. Ovaries from older women had more proteins associated with inflammation and immune activity, as well as the breakdown and rebuilding of tissue around cells. The differences were most pronounced between samples from women in their 50s and those from women aged 70 and older, according to the university’s report.

The research team said the aging ovaries also shared some molecular patterns associated with cellular senescence and ovarian cancer. These are molecular similarities, not a diagnosis: the study does not show that the women had cancer, that the protein patterns predict cancer, or that postmenopausal ovarian changes cause disease. The supplied report gives no evidence that removing healthy ovaries would improve health or longevity.

Why Ovarian Aging May Matter

The findings challenge the assumption that ovaries become biologically inactive once they stop releasing eggs. They suggest that the organ continues to change during a period when many women live for decades, and raise questions about whether those changes relate to health elsewhere in the body. Researchers point to possible connections with organs such as the brain and bones, but this study did not test whether ovarian protein changes cause changes in either.

The cancer-associated molecular patterns also merit further study, but they should not be taken as evidence that normal aging ovaries are cancerous. The work is an early step toward understanding what happens in ovarian tissue after menopause. It does not support a change in medical care, including routine removal of otherwise healthy ovaries. The potential benefits and risks of removal were not assessed.

For readers, the practical takeaway is limited but relevant: the postmenopausal ovary may remain biologically active, while the health meaning of that activity is still unknown. The study provides a map of molecular differences for future research, not a test for individual risk or a basis for treatment decisions.

How Researchers Tracked Change

The team went beyond measuring ovarian hormones and examined the tissue’s protein composition. Proteomics can measure many proteins at once; the researchers used those measurements to identify patterns across samples. They also applied multiple statistical approaches, which, according to co-corresponding author Birgit Schilling, produced a consistent picture of change rather than a stagnant organ.

The study builds on earlier work by co-corresponding author Francesca Duncan’s group, which found evidence of continued remodeling in postmenopausal ovaries in mice. The human findings are consistent with that prior observation, but they do not by themselves establish what the changes do in people. The human analysis covered women from 50 to 75, so it cannot describe ovarian changes across all ages or determine what happens later in life.

““When we analyzed the data in multiple different statistical ways, what became clear across all these methodologies is that the ovary was not stagnant.””

— Birgit Schilling, co-corresponding author and director of the Mass Spectrometry Center at the Buck Institute

What the Protein Patterns Cannot Show

The study does not establish the cause or consequences of the observed changes. It is unclear whether the inflammation-related patterns are harmful, part of normal aging, or have other roles. The researchers also have not shown whether ovarian changes drive changes in other organs, or whether the cancer-associated patterns predict future disease.

The sample included just 28 ovaries from women aged 50 to 75. The supplied report does not provide enough information to assess how representative the samples are of all postmenopausal women or whether factors such as health history affected the results. Nor does it establish whether the patterns differ by time since menopause, or whether they continue in the same way after age 75.

The findings do not answer whether an otherwise healthy ovary ever becomes harmful or whether removing it would improve outcomes. That question would require evidence beyond molecular comparisons in tissue samples. The study is not a clinical trial and does not offer guidance for individual decisions about surgery.

Research Needed Beyond Protein Maps

The immediate next step is to test what the observed protein and tissue changes mean. Researchers will need additional studies to determine how the patterns relate to health over time and whether they correspond to changes in other organs. Larger and more varied human sample collections could help establish how broadly the results apply and clarify differences across age groups.

Longer-term research would also be needed to assess whether particular molecular patterns are linked to later disease or have protective roles. Until those questions are studied, the findings support further investigation rather than changes to screening, treatment or decisions about removing healthy ovaries. No specific follow-up study or clinical milestone is stated in the supplied report.

Key Questions

What did the study find about ovaries after menopause?

In samples from 28 women ages 50 to 75, researchers found protein differences associated with age, including patterns linked to inflammation, immune activity and tissue remodeling. The results suggest that ovaries continue to change after reproductive function ends.

Does the study show that postmenopausal ovaries cause cancer?

No. Researchers reported some molecular patterns associated with ovarian cancer, but the study does not show that normal aging ovaries cause cancer or that these patterns predict who will develop it.

Does this mean healthy ovaries should be removed after menopause?

No. The study did not test ovarian removal or compare health outcomes in women who had surgery with those who did not. It does not provide a basis for changing decisions about surgery.

Could ovarian aging affect other organs?

The researchers raised that possibility, citing potential connections with organs including the brain and bones. This study examined ovarian tissue, however, and did not establish that the observed changes cause effects elsewhere in the body.

Source: hn